Literature DB >> 25382404

Hypoglycaemic activity of culinary Pleurotus ostreatus and P. cystidiosus mushrooms in healthy volunteers and type 2 diabetic patients on diet control and the possible mechanisms of action.

W J A Banukie N Jayasuriya1, Chandanie A Wanigatunge, Gita H Fernando, D Thusitha U Abeytunga, T Sugandhika Suresh.   

Abstract

This study determined the oral hypoglycaemic effect of suspensions of freeze dried and powdered (SFDP) Pleurotus ostreatus (P.o) and Pleurotus cystidiosus (P.c), using healthy human volunteers and Type 2 diabetic patients on diet control at a dose of 50 mg/kg/body weight, followed by a glucose load. The possible hypoglycaemic mechanisms were evaluated using rats, by examining intestinal glucose absorption and serum levels of insulin, glucokinase (GK) and glycogen synthase kinase (GSK). The P.o and P.c showed a significant reduction (P < 0.05) in fasting and postprandial serum glucose levels of healthy volunteers and reduced the postprandial serum glucose levels and increased the serum insulin levels (P < 0.05) of Type 2 diabetic patients. The P.o and P.c increased the intestinal absorption of glucose but simultaneously reduced the serum glucose levels (P < 0.05) in rats. Both mushrooms reduced the serum GSK and promoted insulin secretion while P.c increased serum GK (P < 0.05). The hypoglycaemic activity of P.o and P.c makes mushrooms beneficial functional foods in diabetes mellitus. The mechanism of hypoglycaemic activity of P.o and P.c is possibly by increasing GK activity and promoting insulin secretion and thereby increasing the utilization of glucose by peripheral tissues, inhibiting GSK and promoting glycogen synthesis.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Pleurotus cystidiosus; Pleurotus ostreatus; glucokinase; glycogen synthase kinase; hypoglycaemic; insulin

Mesh:

Substances:

Year:  2014        PMID: 25382404     DOI: 10.1002/ptr.5255

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

Review 1.  Mushroom Polysaccharides: Chemistry and Antiobesity, Antidiabetes, Anticancer, and Antibiotic Properties in Cells, Rodents, and Humans.

Authors:  Mendel Friedman
Journal:  Foods       Date:  2016-11-29

Review 2.  Effect of the Intake of Oyster Mushrooms (Pleurotus ostreatus) on Cardiometabolic Parameters-A Systematic Review of Clinical Trials.

Authors:  Lisa Dicks; Sabine Ellinger
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 3.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

Review 4.  Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials.

Authors:  Giuseppe Venturella; Valeria Ferraro; Fortunato Cirlincione; Maria Letizia Gargano
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

Review 5.  The Effects of Major Mushroom Bioactive Compounds on Mechanisms That Control Blood Glucose Level.

Authors:  Jelena Aramabašić Jovanović; Mirjana Mihailović; Aleksandra Uskoković; Nevena Grdović; Svetlana Dinić; Melita Vidaković
Journal:  J Fungi (Basel)       Date:  2021-01-16

6.  Pleurotus albidus Modulates Mitochondrial Metabolism Disrupted by Hyperglycaemia in EA.hy926 Endothelial Cells.

Authors:  Gabriela Gambato; Elisa Maria Pavão; Gabriela Chilanti; Roselei Claudete Fontana; Mirian Salvador; Marli Camassola
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

7.  Anti-Inflammatory Activity of Pleurotus ostreatus, a Culinary Medicinal Mushroom, in Wistar Rats.

Authors:  W J A Banukie N Jayasuriya; Shiroma M Handunnetti; Chandanie A Wanigatunge; Gita H Fernando; D Thusitha U Abeytunga; T Sugandhika Suresh
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-05       Impact factor: 2.629

8.  Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial.

Authors:  Lisa Dicks; Linda Jakobs; Miriam Sari; Reinhard Hambitzer; Norbert Ludwig; Marie-Christine Simon; Peter Stehle; Birgit Stoffel-Wagner; Hans-Peter Helfrich; Jenny Ahlborn; Martin Rühl; Bolette Hartmann; Jens J Holst; Sabine Ellinger
Journal:  Eur J Nutr       Date:  2021-09-10       Impact factor: 5.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.